In this post we ask what about the patient when healthcare providers plan treatment changes to save money. Is too much emphasis placed on the cost of care?
Any new diagnosis requires a period of adjustment, time to come to terms with the implications and a good support network around you – however, arthritis is particularly challenging. The chances are it’s a condition you have to manage for the rest of your life, dealing with pain along with […]
I’ve been off work the last week with another chest infection, its infuriating, frustrating and detrimental to my career but unfortunately it’s part of daily life when on biologics treatment – but it’s better than the alternative. Arthritis is destructive; it’s your body attacking itself due to your immune system […]
Note: This post continues as part of a series regarding my switchback to Humira in November 2019. You can find earlier posts via the ‘Humira’ tag here: https://joelvsarthritis.co.uk/tag/humira/ So it’s now been over two months since I went back on Humira, approximately six injections and I’m a little disappointed if […]
Note that this post follows on from the a previous blog post which can be found here: https://joelvsarthritis.co.uk/2019/11/15/back-to-the-future-humira-has-arrived/ It’s now been 9 days since I injected Humira again since the switch back. It’s not been the most straight forward introduction as those of you who follow this blog regularly will […]
So today is a big day for me. After 11 months of fighting the reversal of the decision to switch me from Humira to the cheaper Biosimilar Imraldi, which subsequently resulted in one of the biggest flares I’ve had in recent years, the switch back to Humira is finally here! […]
CBD Oil is probably one of the most talked about treatments by patients in arthritis and rheumatology circles right now. Its everywhere and even trusted high street brands such as Holland and Barrett are selling it. However, I personally have no experience of it. For no obvious reason other than […]
Some people have asked me for links to or further reading on the original decision and announcement by the NHS to move to biosimilars at the end of biologics patents in 2018. Below are a couple of high level ones that came out at the time of the announcement. Note […]